Navigation Links
zuChem Receives Two Polyol Patents
Date:6/17/2013

Chicago, IL (PRWEB) June 17, 2013

zuChem Inc., a leading producer of unique carbohydrates for human health and nutrition, announced today that the United States Patent and Trademark office has recently issued 2 patents - US 8,367,346 entitled “Methods for Production of Xylitol in Microorganisms,” and US 8,338,147 entitled "Process for producing D-Mannitol." These two patents expand zuChem's technology portfolio for the fermentative production of natural food sweetener products from abundant, renewable feedstocks.

The xylitol technology was developed by zuChem in collaboration with the U.S. Department of Agriculture, Agricultural Research Service’s National Center for Agricultural Utilization Research and the Biotechnology Research and Development Corporation (BRDC) under a Cooperative Research and Development Agreement. zuChem is the exclusive licensee of this patent under its relationship with the BRDC, to whom this patent is assigned. The mannitol technology was acquired from Hydrios Biotechnology Ltd. of Helsinki, Finland as part of a portfolio of patents developed by Hydrios and the Laboratory of Bioprocess Engineering at Helsinki University of Technology. This technology is now an important component of zuChem’s fermentative mannitol process, which has been approved by the FDA as a safe and effective method for the production of mannitol.

Xylitol and mannitol belong to a class of specialty sweeteners called polyols, and have traditionally been produced from by chemical hydrogenation. The demand for these sweeteners is on the rise because of their unique health properties and growing demand in products such as gum, candy, beverages, diabetic foods and other sugar-free confectionery products. zuChem’s processes are natural fermentative alternatives to the chemical process and utilize readily available biomass as feedstocks.

“We are very pleased by this addition to our intellectual property portfolio on novel biosynthetic production processes of both xylitol and mannitol,” David Demirjian, Ph.D., President and CEO, zuChem. “Our xylitol process is now in scale-up with our first commercial manufacturing partner and we hope to have product on the market in 2014.” Dr. Demirjian is slated to give a presentation of the xylitol process at the World Congress on Industrial Biotechnology on June 17th in Montreal, Canada.

About zuChem, Inc.

zuChem focuses on commercializing innovative manufacturing processes for unique specialized carbohydrates for the food, fine chemicals and pharmaceutical intermediates industries. These specialized carbohydrates are key components of many drugs and drug candidates as well as many specialty food ingredients. The company is headquartered in Chicago, IL, with research operations in Peoria, IL.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10839890.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. UCSB professor receives award for graphene electronics research
2. Watsons Generic Yaz(R) Receives FDA Approval
3. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
4. Life Technologies Ion Personal Genome Machine Receives San Diegos CONNECT Most Innovative New Product Award
5. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
6. Intimate Bridge 2 Conception, Inc. Receives $4.3M
7. Pacific Meso Center Receives Generous Donation to First Free-Standing Mesothelioma Research Laboratory in Los Angeles
8. BioNeutral Group Receives $400,000 in Equity Financing
9. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
10. Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain
11. Life Technologies Receives AFNOR Validation for Tests Designed to Detect Listeria Contamination in Food Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... , Jan. 20, 2017 Ginkgo ... of Gen9, a pioneer in the synthesis and ... unique expertise in assembling pathway-length synthetic DNA into ... and capacity in the construction of new organism ... industries. "Gen9 was founded to significantly ...
(Date:1/19/2017)... and HOUSTON , ... ("NX Prenatal") today announced the formation of its ... leading clinicians and industry veterans who enhance the ... as it accelerates development of its novel prenatal ... provide medical, clinical and strategic guidance for the ...
(Date:1/19/2017)... Md. and GAITHERSBURG, Md. ... (NYSE MKT: PIP) and Altimmune, Inc., a privately-held ... signing of a definitive agreement for the merger ... Altimmune,s current investors include Novartis Venture Fund, HealthCap, ... will be a fully-integrated and diversified immunotherapeutics company ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... FireflySci Inc. ... exponential rate. The tremendous growth is accounted to two main factors. The ... and the expanding network of vendors supplying FireflySci products all around the world. , ...
Breaking Biology Technology:
(Date:12/15/2016)... Dec. 15, 2016 Advancements in ... health wellness and wellbeing (HWW), and security ... three new passenger vehicles begin to feature ... recognition, heart beat monitoring, brain wave monitoring, ... monitoring, and pulse detection. These will be ...
(Date:12/15/2016)... -- "Increase in mobile transactions is driving the growth ... is expected to grow from USD 4.03 billion in ... CAGR of 29.3% between 2016 and 2022. The market ... for smart devices, government initiatives, and increasing penetration of ... expected to grow at a high rate during the ...
(Date:12/8/2016)... Market Research Future published a half cooked research report on Mobile ... Service Market is expected to grow over the CAGR of ~35% ... ... Mobile Biometric Security and Service Market is increasing at ... and security from unwanted cyber threats. The increasing use of mobile ...
Breaking Biology News(10 mins):